Immunicon offers products and services for cell analysis and molecular research. Our CellTracks® instruments and reagents are used to capture, count and characterize rare cells including circulating tumor cells (CTCs) in cancer patients and circulating endothelial cells (CECs), which are elevated in a variety of diseases.

The top names in Big Pharma are working with Immunicon Pharma Services. We offer biomarker assay development for protein or molecular targets associated with their agents. We also offer clinical trial testing services to incorporate rare cell analysis and FISH testing into clinical research.

Our life science research product portfolio includes the EasyCount® System for counting nucleated cells.